<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>hiv aids</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>hiv aids | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal Meningitis.
Authors: Kasibante, J.; Ifarnullah, E.; Wele, A.; Okafor, E.; Ssebambulidde, K.; Okurut, S.; Kagimu, E.; Gakuru, J.; Rutakingirw, M. K.; Mugabi, T.; Nuwagira, E.; Jjunju, S.; Mpoza, E.; Tugume, L.; Nsangi, L.; Musubire, A.; Muzoora, C.; Rhein, J.; Meya, D.; Boulware, D. R.; Abassi, M.
Score: 3.8, Published: 2023-12-12 DOI: 10.1101/2023.12.10.23299793">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/hiv-aids/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="hiv aids" />
<meta property="og:description" content="Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal Meningitis.
Authors: Kasibante, J.; Ifarnullah, E.; Wele, A.; Okafor, E.; Ssebambulidde, K.; Okurut, S.; Kagimu, E.; Gakuru, J.; Rutakingirw, M. K.; Mugabi, T.; Nuwagira, E.; Jjunju, S.; Mpoza, E.; Tugume, L.; Nsangi, L.; Musubire, A.; Muzoora, C.; Rhein, J.; Meya, D.; Boulware, D. R.; Abassi, M.
Score: 3.8, Published: 2023-12-12 DOI: 10.1101/2023.12.10.23299793" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/hiv-aids/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-12-20T10:36:27+00:00" />
<meta property="article:modified_time" content="2023-12-20T10:36:27+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="hiv aids"/>
<meta name="twitter:description" content="Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal Meningitis.
Authors: Kasibante, J.; Ifarnullah, E.; Wele, A.; Okafor, E.; Ssebambulidde, K.; Okurut, S.; Kagimu, E.; Gakuru, J.; Rutakingirw, M. K.; Mugabi, T.; Nuwagira, E.; Jjunju, S.; Mpoza, E.; Tugume, L.; Nsangi, L.; Musubire, A.; Muzoora, C.; Rhein, J.; Meya, D.; Boulware, D. R.; Abassi, M.
Score: 3.8, Published: 2023-12-12 DOI: 10.1101/2023.12.10.23299793"/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "hiv aids",
      "item": "https://trxiv.yorks0n.com/posts/hiv-aids/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "hiv aids",
  "name": "hiv aids",
  "description": "Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal Meningitis.\nAuthors: Kasibante, J.; Ifarnullah, E.; Wele, A.; Okafor, E.; Ssebambulidde, K.; Okurut, S.; Kagimu, E.; Gakuru, J.; Rutakingirw, M. K.; Mugabi, T.; Nuwagira, E.; Jjunju, S.; Mpoza, E.; Tugume, L.; Nsangi, L.; Musubire, A.; Muzoora, C.; Rhein, J.; Meya, D.; Boulware, D. R.; Abassi, M.\nScore: 3.8, Published: 2023-12-12 DOI: 10.1101/2023.12.10.23299793",
  "keywords": [
    
  ],
  "articleBody": " Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal Meningitis.\nAuthors: Kasibante, J.; Ifarnullah, E.; Wele, A.; Okafor, E.; Ssebambulidde, K.; Okurut, S.; Kagimu, E.; Gakuru, J.; Rutakingirw, M. K.; Mugabi, T.; Nuwagira, E.; Jjunju, S.; Mpoza, E.; Tugume, L.; Nsangi, L.; Musubire, A.; Muzoora, C.; Rhein, J.; Meya, D.; Boulware, D. R.; Abassi, M.\nScore: 3.8, Published: 2023-12-12 DOI: 10.1101/2023.12.10.23299793\nBackgroundCerebrospinal fluid (CSF) protein levels exhibit high variability in HIV-associated cryptococcal meningitis from being normal to markedly elevated. However, the clinical implications of CSF protein levels in cryptococcal meningitis remain unclear. MethodsWe analysed data from 890 adults with HIV-associated cryptococcal meningitis randomized into two clinical trials in Uganda between 2015 and 2021. CSF protein was grouped into [\u0026ge;]100 mg/dL (n=249) and \u003c100 mg/dL (n=641). We described baseline clinical variables and mortality by CSF protein levels. ResultsApproximately one-third of individuals had a baseline CSF protein [\u0026ge;]100 mg/dL. Those with CSF protein [\u0026ge;]100 mg/dL were more likely to present with Glasgow coma scale scores \u003c15 (P\u003c0.01), self-reported seizures at baseline (P=0.02), higher CD4 T-cells (p\u003c0.001), and higher CSF white cells (p\u003c0.001). Moreover, those with a baseline CSF protein [\u0026ge;]100 mg/dL also had a lower baseline CSF fungal burden (p\u003c0.001) and a higher percentage of sterile CSF cultures at day 14 (p=0.02). Individuals with CSF protein [\u0026ge;]100 mg/dL demonstrated a more pronounced immune response consisting of upregulation of immune effector molecules pro-inflammatory cytokines, type-1 T-helper cell cytokines, type-3 chemokines, and immune-exhaustion marker (p\u003c0.05). 18-week mortality risk in individuals with a CSF protein \u003c100 mg/dL was 34% higher, (unadjusted Hazard Ratio 1.34; 95% CI, 1.05 to 1.70; p=0.02) than those with [\u0026ge;]100 mg/dL. ConclusionIn cryptococcal meningitis, individuals with CSF protein [\u0026ge;]100 mg/dL more frequently presented with seizures, altered mental status, immune activation, and favourable fungal outcomes. Baseline CSF protein levels may serve as a surrogate marker of immune activation and prognosis.\nThe global burden of HIV among Long-distance truck drivers: A systematic review and meta-analysis\nAuthors: MUTIE, C.; Otieno, B.; Mwangi, E.; Kawira, R.; Mutisya, A.; Gachohi, J.; Mbuthia, G.\nScore: 1.1, Published: 2023-12-19 DOI: 10.1101/2023.12.18.23300177\nLong-distance truck drivers (LDTDs) endure a disproportionately high burden of HIV in various global settings. However, unlike other most at-risk populations, the global burden of HIV among LDTDs has not been documented so far. The result has been poor allocation and distribution of the limited HIV preventive resources for LDTDs in most parts of the world. Thus, a systematic review and meta-analysis were conducted to assess the global burden of HIV among LDTDs. A comprehensive electronic search was conducted in PubMed, ProQuest Central, PubMed Central, CINAHL, and Global Index Medicus to identify relevant information published in English on HIV prevalence among LDTDs from 1989 to the 16th of May 2023. A random-effects meta-analysis was conducted to establish the burden of HIV at global and regional levels. The Joanna Briggs Institute (JBI) and Newcastle-Ottawa Scale (NOS) tools were used to assess the quality of the included studies. Of the 1787 articles identified, 43 were included. Most of the included studies were conducted in sub-Saharan Africa (44.19%, n=19), and Asia and the Pacific (37.21%, n=16). The pooled prevalence of HIV was 3.82%. The burden of HIV was highest in sub-Saharan Africa at 14.34%, followed by Asia and the Pacific at 2.14%, and lastly Western, Central Europe and North America at 0.17%. The overall heterogeneity score was (I2 = 98.2%, p \u003c 0.001). The global burden of HIV among LDTDs is 3.82%, six times higher than that of the general population globally. Compared to other regions, the burden of HIV is highest in sub-Saharan Africa at 14.34%, where its estimated to be 3% in the general population. Thus, LDTDs endure a disproportionately high burden of HIV compared to other populations. Consequently, more LDTD-centred HIV research and surveillance is needed at national and regional levels to institute tailored preventive policies and interventions.\n",
  "wordCount" : "649",
  "inLanguage": "en",
  "datePublished": "2023-12-20T10:36:27Z",
  "dateModified": "2023-12-20T10:36:27Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/hiv-aids/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      hiv aids
    </h1>
    <div class="post-meta">&lt;span&gt;updated on December 20, 2023&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.10.23299793">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.10.23299793" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.10.23299793">
        <p class="paperTitle">Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal Meningitis.</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.10.23299793" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.10.23299793" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Kasibante, J.; Ifarnullah, E.; Wele, A.; Okafor, E.; Ssebambulidde, K.; Okurut, S.; Kagimu, E.; Gakuru, J.; Rutakingirw, M. K.; Mugabi, T.; Nuwagira, E.; Jjunju, S.; Mpoza, E.; Tugume, L.; Nsangi, L.; Musubire, A.; Muzoora, C.; Rhein, J.; Meya, D.; Boulware, D. R.; Abassi, M.</p>
        <p class="info">Score: 3.8, Published: 2023-12-12 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.10.23299793' target='https://doi.org/10.1101/2023.12.10.23299793'> 10.1101/2023.12.10.23299793</a></p>
        <p class="abstract">BackgroundCerebrospinal fluid (CSF) protein levels exhibit high variability in HIV-associated cryptococcal meningitis from being normal to markedly elevated. However, the clinical implications of CSF protein levels in cryptococcal meningitis remain unclear.

MethodsWe analysed data from 890 adults with HIV-associated cryptococcal meningitis randomized into two clinical trials in Uganda between 2015 and 2021. CSF protein was grouped into [&amp;ge;]100 mg/dL (n=249) and &lt;100 mg/dL (n=641). We described baseline clinical variables and mortality by CSF protein levels.

ResultsApproximately one-third of individuals had a baseline CSF protein [&amp;ge;]100 mg/dL. Those with CSF protein [&amp;ge;]100 mg/dL were more likely to present with Glasgow coma scale scores &lt;15 (P&lt;0.01), self-reported seizures at baseline (P=0.02), higher CD4 T-cells (p&lt;0.001), and higher CSF white cells (p&lt;0.001). Moreover, those with a baseline CSF protein [&amp;ge;]100 mg/dL also had a lower baseline CSF fungal burden (p&lt;0.001) and a higher percentage of sterile CSF cultures at day 14 (p=0.02). Individuals with CSF protein [&amp;ge;]100 mg/dL demonstrated a more pronounced immune response consisting of upregulation of immune effector molecules pro-inflammatory cytokines, type-1 T-helper cell cytokines, type-3 chemokines, and immune-exhaustion marker (p&lt;0.05). 18-week mortality risk in individuals with a CSF protein &lt;100 mg/dL was 34% higher, (unadjusted Hazard Ratio 1.34; 95% CI, 1.05 to 1.70; p=0.02) than those with [&amp;ge;]100 mg/dL.

ConclusionIn cryptococcal meningitis, individuals with CSF protein [&amp;ge;]100 mg/dL more frequently presented with seizures, altered mental status, immune activation, and favourable fungal outcomes. Baseline CSF protein levels may serve as a surrogate marker of immune activation and prognosis.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.18.23300177">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.18.23300177" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.18.23300177">
        <p class="paperTitle">The global burden of HIV among Long-distance truck drivers: A systematic review and meta-analysis</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.18.23300177" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.18.23300177" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: MUTIE, C.; Otieno, B.; Mwangi, E.; Kawira, R.; Mutisya, A.; Gachohi, J.; Mbuthia, G.</p>
        <p class="info">Score: 1.1, Published: 2023-12-19 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.18.23300177' target='https://doi.org/10.1101/2023.12.18.23300177'> 10.1101/2023.12.18.23300177</a></p>
        <p class="abstract">Long-distance truck drivers (LDTDs) endure a disproportionately high burden of HIV in various global settings. However, unlike other most at-risk populations, the global burden of HIV among LDTDs has not been documented so far. The result has been poor allocation and distribution of the limited HIV preventive resources for LDTDs in most parts of the world. Thus, a systematic review and meta-analysis were conducted to assess the global burden of HIV among LDTDs. A comprehensive electronic search was conducted in PubMed, ProQuest Central, PubMed Central, CINAHL, and Global Index Medicus to identify relevant information published in English on HIV prevalence among LDTDs from 1989 to the 16th of May 2023. A random-effects meta-analysis was conducted to establish the burden of HIV at global and regional levels. The Joanna Briggs Institute (JBI) and Newcastle-Ottawa Scale (NOS) tools were used to assess the quality of the included studies. Of the 1787 articles identified, 43 were included. Most of the included studies were conducted in sub-Saharan Africa (44.19%, n=19), and Asia and the Pacific (37.21%, n=16). The pooled prevalence of HIV was 3.82%. The burden of HIV was highest in sub-Saharan Africa at 14.34%, followed by Asia and the Pacific at 2.14%, and lastly Western, Central Europe and North America at 0.17%. The overall heterogeneity score was (I2 = 98.2%, p &lt; 0.001). The global burden of HIV among LDTDs is 3.82%, six times higher than that of the general population globally. Compared to other regions, the burden of HIV is highest in sub-Saharan Africa at 14.34%, where its estimated to be 3% in the general population. Thus, LDTDs endure a disproportionately high burden of HIV compared to other populations. Consequently, more LDTD-centred HIV research and surveillance is needed at national and regional levels to institute tailored preventive policies and interventions.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
